Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
2005-7-20
pubmed:abstractText
We have shown previously that the SLC12A3 +78G/A polymorphism in exon 23 (Arg913Gln) was a new candidate for conferring susceptibility to diabetic nephropathy. The aim of this study was to confirm the effect of this polymorphism on the elevation of urinary albumin excretion in type 2 diabetic patients.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0012-186X
pubmed:author
pubmed:issnType
Print
pubmed:volume
48
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1335-8
pubmed:dateRevised
2005-11-17
pubmed:meshHeading
pubmed-meshheading:15915338-Albuminuria, pubmed-meshheading:15915338-Amino Acid Substitution, pubmed-meshheading:15915338-Angiotensin-Converting Enzyme Inhibitors, pubmed-meshheading:15915338-Blood Pressure, pubmed-meshheading:15915338-Calcium Channel Blockers, pubmed-meshheading:15915338-Cholesterol, pubmed-meshheading:15915338-Diabetes Mellitus, Type 2, pubmed-meshheading:15915338-Diabetic Retinopathy, pubmed-meshheading:15915338-Exons, pubmed-meshheading:15915338-Female, pubmed-meshheading:15915338-Hemoglobin A, Glycosylated, pubmed-meshheading:15915338-Humans, pubmed-meshheading:15915338-Japan, pubmed-meshheading:15915338-Longitudinal Studies, pubmed-meshheading:15915338-Male, pubmed-meshheading:15915338-Middle Aged, pubmed-meshheading:15915338-Polymorphism, Single Nucleotide, pubmed-meshheading:15915338-Receptors, Drug, pubmed-meshheading:15915338-Smoking, pubmed-meshheading:15915338-Sodium Chloride Symporters, pubmed-meshheading:15915338-Symporters, pubmed-meshheading:15915338-Triglycerides
pubmed:year
2005
pubmed:articleTitle
Polymorphism of the solute carrier family 12 (sodium/chloride transporters) member 3, SLC12A3, gene at exon 23 (+78G/A: Arg913Gln) is associated with elevation of urinary albumin excretion in Japanese patients with type 2 diabetes: a 10-year longitudinal study.
pubmed:affiliation
Department of Medicine, Metabolism and Endocrinology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.
pubmed:publicationType
Journal Article